Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Vaccine Candidate Effective Against Multiple Fungal Infections

People with diabetes, COPD, or co-infections such as COVID-19, tuberculosis or flu, are at higher risk of developing fungal infections.

Chronic Pulmonary Disorders

Tezepelumab Reduced, Eliminated OCS Use in Severe Asthma Patients

Treatment with tezepelumab (Tezspire) can substantially reduce or eliminate oral corticosteroid (OCS) use in adults with OCS-dependent severe asthma, according to new Phase 3 WAYFINDER results presented at ATS 2025.

Chronic Pulmonary Disorders

Ciliary Dysfunction Linked to Bronchopulmonary Dysplasia Severity

Infants with more severe bronchopulmonary dysplasia showed signs of ciliary dysfunction that were not present in those with moderate disease.

Asthma

After Flovent Pulled, Asthmatic Kids Quit Inhalers

Study suggests the 2024 withdrawal of the asthma medication Flovent was linked to increases in children discontinuing inhaled steroid therapy.

COPD

Perceived Stress Has Deleterious Effects on COPD Symptoms, Quality of Life

Higher levels of perceived stress—or how overwhelmed or stressed a person feels based on their personal understanding of their condition—can have physiological impacts on a COPD patient's disease symptoms.

Cystic fibrosis

Cystic Fibrosis and Abnormal Lung Function

Changes in lung function are of critical importance to patients with cystic fibrosis (CF), as lung function is a key indicator of disease progression and treatment effectiveness.

Pulmonary Fibrosis

Cancer Drug May Have Applications for Pulmonary Fibrosis

An FDA-approved cancer drug may help the immune system clear out damaged cells that cause the lung scarring, potentially restoring lung function in patients with pulmonary fibrosis.

Allergies

Intestinal Immune Cell Prevents Food Allergies

A small population of immune cells in the intestine prevented allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.

Other Chronic Diseases

Bronchiectasis: Brensocatib Reduced Exacerbations, Slowed Lung Function Decline

Brensocatib significantly reduced the rate of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis compared to placebo.